STADA Competitors and Similar CompaniesClear all
Karyopharm Therapeutics's competitors and similar companies include Sol-Gel Technologies.
 Karyopharm Therapeutics Karyopharm Therapeutics is a commercial-stage pharmaceutical company that pioneers in cancer therapies. |  Sol-Gel Technologies Sol-Gel Technologies is engaged in the development of a range of specialty pharmaceuticals. | |
Founding Date | Founding Date 2008 | Founding Date 1997 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Newton, US HQ Givatayim, IL | Locations Ness Ziona, IL HQ |
Employees | Employees 22818% decrease | Employees 34 |
Valuation ($) | Valuation ($) 111.7 m | Valuation ($) 18 m |
Financial | ||
Revenue (est.) | Revenue (est.) $146.1m (FY, 2025) | Revenue (est.) $19.4m (FY, 2025) |
Cost of goods | Cost of goods $5.9m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $140.1m (FY, 2025) | Gross profit $19.4m (FY, 2025) |
Net income | Net income ($196m) (FY, 2025) | Net income ($6.1m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Sol-Gel Technologies
HQ
Ness Ziona, IL
Employees
34
Sol-Gel Technologies is engaged in the development of a range of specialty pharmaceuticals.
View company